[Safety of Zyban administration in nicotine dependence treatment].
Zyban (bupropion hydrochloride, produced by Glaxo Wellcome Group) is a drug available in Poland used in a nicotine dependence treatment, as an aid in smoking cessation. The aim of the study was to review available information concerning observed side-effects of Zyban. The information provided by producer, articles and reports published in MEDLINE and EMBASE databases since January 2001 till September 2004 were analysed. Side-effects were analysed, compared and classified according to anatomy-physiological systems, where these side-effects are observed.